2-[4-[3-[[1-(2-cyanophenyl)piperidin-4-yl]methyl]-4-methylbenzoyl]piperazin-1-yl]benzenesulfonamide;methane
C32H39N5O3S — CID 158735984
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[3-[[1-(2-cyanophenyl)piperidin-4-yl]methyl]-4-methylbenzoyl]piperazin-1-yl]benzenesulfonamide;methane
2-[4-[3-[[1-(2-cyanophenyl)piperidin-4-yl]methyl]-4-methylbenzoyl]piperazin-1-yl]benzenesulfonamide;methane (PubChem CID 158735984) has the molecular formula C32H39N5O3S and a molecular weight of 573.76 g/mol. Its IUPAC name is 2-[4-[3-[[1-(2-cyanophenyl)piperidin-4-yl]methyl]-4-methylbenzoyl]piperazin-1-yl]benzenesulfonamide;methane.
Molecular Properties
| Compound Name | 2-[4-[3-[[1-(2-cyanophenyl)piperidin-4-yl]methyl]-4-methylbenzoyl]piperazin-1-yl]benzenesulfonamide;methane |
|---|---|
| PubChem CID | 158735984 |
| Molecular Formula | C32H39N5O3S |
| Molecular Weight | 573.76 g/mol |
| Exact Mass | 573.28 |
| IUPAC Name | 2-[4-[3-[[1-(2-cyanophenyl)piperidin-4-yl]methyl]-4-methylbenzoyl]piperazin-1-yl]benzenesulfonamide;methane |
| SMILES | C.Cc1ccc(C(=O)N2CCN(c3ccccc3S(N)(=O)=O)CC2)cc1CC1CCN(c2ccccc2C#N)CC1 |
| InChI | InChI=1S/C31H35N5O3S.CH4/c1-23-10-11-25(21-27(23)20-24-12-14-34(15-13-24)28-7-3-2-6-26(28)22-32)31(37)36-18-16-35(17-19-36)29-8-4-5-9-30(29)40(33,38)39;/h2-11,21,24H,12-20H2,1H3,(H2,33,38,39);1H4 |
| InChIKey | ILRKJQJXHIPORZ-UHFFFAOYSA-N |
| XLogP | 4.57 |
| TPSA | 110.74 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 573.76 |
| LogP ≤ 5 | 4.57 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158735984 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.